Name | Number of supported studies | Average coverage | |
---|---|---|---|
amacrine cell | 8 studies | 52% ± 5% | |
retina horizontal cell | 7 studies | 67% ± 10% | |
GABAergic amacrine cell | 4 studies | 52% ± 6% | |
glycinergic amacrine cell | 3 studies | 30% ± 9% | |
kidney loop of Henle epithelial cell | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of TFAP2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 63% | 1952.85 | 288 / 459 | 55% | 42.91 | 615 / 1118 |
kidney | 100% | 1233.39 | 89 / 89 | 3% | 0.41 | 24 / 901 |
adrenal gland | 24% | 192.63 | 62 / 258 | 65% | 42.22 | 149 / 230 |
skin | 72% | 784.21 | 1305 / 1809 | 14% | 5.75 | 64 / 472 |
esophagus | 38% | 359.71 | 542 / 1445 | 2% | 0.10 | 3 / 183 |
brain | 19% | 167.88 | 495 / 2642 | 3% | 0.28 | 18 / 705 |
intestine | 4% | 10.57 | 43 / 966 | 0% | 0.10 | 2 / 527 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.84 | 19 / 504 |
adipose | 3% | 9.89 | 37 / 1204 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 3% | 0.44 | 13 / 459 |
eye | 0% | 0 | 0 / 0 | 3% | 0.27 | 2 / 80 |
lung | 0% | 0.31 | 1 / 578 | 2% | 0.99 | 26 / 1155 |
prostate | 2% | 3.81 | 5 / 245 | 0% | 0 | 0 / 502 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.08 | 2 / 178 |
blood vessel | 1% | 3.08 | 14 / 1335 | 0% | 0 | 0 / 0 |
stomach | 0% | 0.36 | 1 / 359 | 0% | 0 | 0 / 286 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.03 | 1 / 430 |
peripheral blood | 0% | 1.76 | 2 / 929 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.03 | 1 / 605 |
muscle | 0% | 0.16 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.46 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0072017 | Biological process | distal tubule development |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0035136 | Biological process | forelimb morphogenesis |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0030510 | Biological process | regulation of BMP signaling pathway |
GO_0001822 | Biological process | kidney development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0035137 | Biological process | hindlimb morphogenesis |
GO_0072210 | Biological process | metanephric nephron development |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0035909 | Biological process | aorta morphogenesis |
GO_0072044 | Biological process | collecting duct development |
GO_0097070 | Biological process | ductus arteriosus closure |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0048856 | Biological process | anatomical structure development |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0043588 | Biological process | skin development |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0006006 | Biological process | glucose metabolic process |
GO_0048745 | Biological process | smooth muscle tissue development |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0010842 | Biological process | retina layer formation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TFAP2B |
Protein name | Transcription factor AP-2 beta Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta) |
Synonyms | |
Description | FUNCTION: Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia. . |
Accessions | Q92481 ENST00000344788.7 ENST00000393655.4 [Q92481-1] X6R4Y8 |